Praxis precision medicines to announce second quarter 2024 financial results and host conference call on tuesday, august 13, 2024

Boston, aug. 05, 2024 (globe newswire) -- praxis precision medicines, inc. (nasdaq: prax), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (cns) disorders characterized by neuronal excitation-inhibition imbalance, today announced it will report its financial results from the second quarter ended june 30, 2024, before the financial markets open on tuesday, august 13, 2024.
PRAX Ratings Summary
PRAX Quant Ranking